BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12145154)

  • 1. Liver X receptors downregulate 11beta-hydroxysteroid dehydrogenase type 1 expression and activity.
    Stulnig TM; Oppermann U; Steffensen KR; Schuster GU; Gustafsson JA
    Diabetes; 2002 Aug; 51(8):2426-33. PubMed ID: 12145154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity.
    Berger J; Tanen M; Elbrecht A; Hermanowski-Vosatka A; Moller DE; Wright SD; Thieringer R
    J Biol Chem; 2001 Apr; 276(16):12629-35. PubMed ID: 11278270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated.
    Napolitano A; Voice MW; Edwards CR; Seckl JR; Chapman KE
    J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):251-60. PubMed ID: 9618026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.
    Liang G; Yang J; Horton JD; Hammer RE; Goldstein JL; Brown MS
    J Biol Chem; 2002 Mar; 277(11):9520-8. PubMed ID: 11782483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors.
    Joseph SB; Laffitte BA; Patel PH; Watson MA; Matsukuma KE; Walczak R; Collins JL; Osborne TF; Tontonoz P
    J Biol Chem; 2002 Mar; 277(13):11019-25. PubMed ID: 11790787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7-oxysterols modulate glucocorticoid activity in adipocytes through competition for 11beta-hydroxysteroid dehydrogenase type.
    Wamil M; Andrew R; Chapman KE; Street J; Morton NM; Seckl JR
    Endocrinology; 2008 Dec; 149(12):5909-18. PubMed ID: 18755798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver.
    Hermanowski-Vosatka A; Gerhold D; Mundt SS; Loving VA; Lu M; Chen Y; Elbrecht A; Wu M; Doebber T; Kelly L; Milot D; Guo Q; Wang PR; Ippolito M; Chao YS; Wright SD; Thieringer R
    Biochem Biophys Res Commun; 2000 Dec; 279(2):330-6. PubMed ID: 11118287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the role of liver X receptors in lipid accumulation in adipocytes.
    Juvet LK; Andresen SM; Schuster GU; Dalen KT; Tobin KA; Hollung K; Haugen F; Jacinto S; Ulven SM; Bamberg K; Gustafsson JA; Nebb HI
    Mol Endocrinol; 2003 Feb; 17(2):172-82. PubMed ID: 12554745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1.
    Jamieson PM; Nyirenda MJ; Walker BR; Chapman KE; Seckl JR
    J Endocrinol; 1999 Jan; 160(1):103-9. PubMed ID: 9854182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny and sexual dimorphic expression of mouse type 2 11beta-hydroxysteroid dehydrogenase.
    Condon J; Ricketts ML; Whorwood CB; Stewart PM
    Mol Cell Endocrinol; 1997 Mar; 127(2):121-8. PubMed ID: 9099907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice.
    Morton NM; Holmes MC; Fiévet C; Staels B; Tailleux A; Mullins JJ; Seckl JR
    J Biol Chem; 2001 Nov; 276(44):41293-300. PubMed ID: 11546766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification, characterization and NNK carbonyl reductase activities of 11beta-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen.
    Maser E; Friebertshäuser J; Völker B
    Chem Biol Interact; 2003 Feb; 143-144():435-48. PubMed ID: 12604230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific messenger ribonucleic acid expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within rat placenta suggests exquisite local control of glucocorticoid action.
    Waddell BJ; Benediktsson R; Brown RW; Seckl JR
    Endocrinology; 1998 Apr; 139(4):1517-23. PubMed ID: 9528929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study.
    Paulmyer-Lacroix O; Boullu S; Oliver C; Alessi MC; Grino M
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2701-5. PubMed ID: 12050237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR.
    Ou J; Tu H; Shan B; Luk A; DeBose-Boyd RA; Bashmakov Y; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6027-32. PubMed ID: 11371634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of 11beta-hydroxysteroid dehydrogenase type 2 in an ACTH-producing small cell lung cancer.
    Parks LL; Turney MK; Gaitan D; Kovacs WJ
    J Steroid Biochem Mol Biol; 1998 Nov; 67(4):341-6. PubMed ID: 9883991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of liver X receptors prevents statin-induced death of 3T3-L1 preadipocytes.
    Madsen L; Petersen RK; Steffensen KR; Pedersen LM; Hallenborg P; Ma T; Frøyland L; Døskeland SO; Gustafsson JA; Kristiansen K
    J Biol Chem; 2008 Aug; 283(33):22723-36. PubMed ID: 18487205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific regulation of 11β hydroxysteroid dehydrogenase type-1 mRNA expressions in Cushing's syndrome mouse model.
    Nishiyama M; Iwasaki Y; Nakayama S; Okazaki M; Taguchi T; Tsuda M; Makino S; Fujimoto S; Terada Y
    Steroids; 2022 Jul; 183():109021. PubMed ID: 35339573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice.
    Alberts P; Engblom L; Edling N; Forsgren M; Klingström G; Larsson C; Rönquist-Nii Y; Ohman B; Abrahmsén L
    Diabetologia; 2002 Nov; 45(11):1528-32. PubMed ID: 12436336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human adipose tissue under in vitro inhibition of 11beta-hydroxysteroid dehydrogenase type 1: differentiation and metabolism changes.
    Bader T; Zoumakis E; Friedberg M; Hiroi N; Chrousos GP; Hochberg Z
    Horm Metab Res; 2002; 34(11-12):752-7. PubMed ID: 12660894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.